Form 13-F position report

* MYRIAD GENETICS INC

Reported by THE BANK OF NEW YORK MELLON CORPORATION

MYGN CUSIP 62855J104 Manager CIK 0001390777

Reported 740,181 shares, down 17,697 (2.3%) from the prior quarter.

Reported value -2.5%; share count -2.3% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q2 2023
Shares 740,181 Quarter-end amount reported
Reported value $17,157,396 Fair value at quarter end
Consecutive quarters held 41 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 29939000
2021-12-31 25783000
2022-03-31 23335000
2022-06-30 14981000
2022-09-30 16055000
2022-12-31 11770338
2023-03-31 17605505
2023-06-30 17157396
2023-09-30 11256133
2023-12-31 13686855
2024-03-31 14735865
2024-06-30 17593850
2024-09-30 17632222
2024-12-31 8856697
2025-03-31 5516604
2025-06-30 3319397
2025-09-30 4229244
2025-12-31 3579993
2026-03-31 1505308
2026-06-30 1929647

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for * MYRIAD GENETICS INC held by THE BANK OF NEW YORK MELLON CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Added 337,942 +3,429 (1.0%) < 0.01% $1,929,647 2026-08-06
Q1 2026 Reduced 334,513 -247,600 (-42.5%) < 0.01% $1,505,308 2026-05-05
Q4 2025 Reduced 582,113 -2,845 (-0.5%) < 0.01% $3,579,993 2026-02-10
Q3 2025 Reduced 584,958 -40,164 (-6.4%) < 0.01% $4,229,244 2025-11-03
Q2 2025 Added 625,122 +3,182 (0.5%) < 0.01% $3,319,397 2025-08-05
Q1 2025 Reduced 621,940 -24,063 (-3.7%) < 0.01% $5,516,604 2025-04-29
Q4 2024 Added 646,003 +2,256 (0.4%) < 0.01% $8,856,697 2025-02-04
Q3 2024 Reduced 643,747 -75,544 (-10.5%) < 0.01% $17,632,222 2024-11-12
Q2 2024 Added 719,291 +28,115 (4.1%) < 0.01% $17,593,850 2024-07-25
Q1 2024 Reduced 691,176 -23,916 (-3.3%) < 0.01% $14,735,865 2024-04-25
Q4 2023 Added 715,092 +13,338 (1.9%) < 0.01% $13,686,855 2024-01-29
Q3 2023 Reduced 701,754 -38,427 (-5.2%) < 0.01% $11,256,133 2023-10-24
Q2 2023 Reduced 740,181 -17,697 (-2.3%) < 0.01% $17,157,396 2023-08-03
Q1 2023 Reduced 757,878 -53,310 (-6.6%) < 0.01% $17,605,505 2023-05-09
Q4 2022 Reduced 811,188 -30,235 (-3.6%) < 0.01% $11,770,338 2023-02-14
Q3 2022 Added 841,423 +17,009 (2.1%) < 0.01% $16,055,000 2022-11-14
Q2 2022 Reduced 824,414 -101,548 (-11.0%) < 0.01% $14,981,000 2022-08-15
Q1 2022 Reduced 925,962 -8,217 (-0.9%) < 0.01% $23,335,000 2022-05-11
Q4 2021 Added 934,179 +6,949 (0.7%) < 0.01% $25,783,000 2022-02-11
Q3 2021 Added 927,230 +31,642 (3.5%) < 0.01% $29,939,000 2021-11-12
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

211 managers reported * MYRIAD GENETICS INC for Q2 2023.

Managers reporting * MYRIAD GENETICS INC in Q2 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 14,104,604 -23,104 < 0.01% $326,944,722 41 qtrs
VANGUARD GROUP INC Reduced 9,152,347 -146,067 < 0.01% $212,151,404 41 qtrs
Camber Capital Management LP Reduced 6,635,000 -365,000 5.01% $153,799,000 16 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 5,744,834 -986,005 0.03% $133,165,252 10 qtrs
STATE STREET CORPORATION Added 4,722,988 +120,069 < 0.01% $109,478,862 41 qtrs
GLENVIEW CAPITAL MANAGEMENT LLC Reduced 3,744,888 -450,224 1.96% $86,806,504 16 qtrs
EARNEST PARTNERS LLC Added 3,253,778 +192,940 0.42% $75,422,574 16 qtrs
Bank of America Corporation Reduced 2,970,821 -462,148 < 0.01% $68,863,631 41 qtrs
DIMENSIONAL FUND ADVISORS LP Reduced 2,673,471 -50,925 0.02% $61,970,696 41 qtrs
Artisan Partners Limited Partnership Added 2,538,065 +331,207 0.09% $58,832,347 9 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
August 03, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
686,600
Shared
0
None
53,581

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.